You are viewing an incomplete version of our website. Please click to reload the website as full version.

BCL2 antibody (B-Cell CLL/lymphoma 2)

Details for Product anti-BCL2 Antibody No. ABIN114624, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

(694), (201), (150), (17), (9), (7), (4), (3), (2), (2), (1), (1)
(504), (249), (20), (6), (2), (2), (2)
Clonality (Clone)
Monoclonal ()
This BCL2 antibody is un-conjugated
(38), (34), (27), (24), (18), (14), (11), (10), (8), (6), (6), (6), (6), (6), (6), (3), (1), (1), (1), (1)
Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunoprecipitation (IP), Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
(493), (277), (243), (151), (141), (140), (123), (68), (48), (42), (38), (11), (11), (10), (8), (8), (5), (1), (1), (1), (1), (1)
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 1 mL
Shipping to United States ( )
Immunogen BALB/C mice were injected with synthetic bcl-2 peptide.
Clone 100-D5
Isotype IgG1
Specificity The bcl-2 product is considered to act as an inhibitor of apoptosis. bcl-2 is expression is inhibited in germinal centers where apoptosis forms part of B cell production pathway. Reactive follicle show no staining for bcl-2, where as the cells in neoplastic follicles exhibit membrane staining. Cellular Localization: Cell membrane
Purification Purified
Alternative Name Bcl-2 (BCL2 Antibody Abstract)
Background BCL2 is an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants (alpha and beta) produced by alternate splicing, differ in their C-terminal ends. BCL2 suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. It regulates cell death by controlling the mitochondrial membrane permeability. It appears to function in a feedback loop system with caspases. BCL2 inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF1). It can form homodimers, and heterodimers with BAX, BAD, BAK and BclX(L). Heterodimerization with BAX requires intact BH1 and BH2 domains, and is necessary for anti-apoptotic activity. Also interacts with APAF1, RAF1, TP53BP2, BBC3, BCL2L1 and BNIPL.
Alternate names: Apoptosis regulator Bcl-2, B-Cell CLL/lymphoma 2, BCL2, Bcl-2 alpha
Gene ID 596
NCBI Accession NP_000624
UniProt P10415
Research Area Cancer, Apoptosis/Necrosis
Pathways MAPK Signaling, PI3K-Akt Signaling, Apoptosis, Caspase Cascade in Apoptosis
Application Notes Immunoprecipitation: 1/50Western blot: 1/50-1/100Immunohistochemistry on Formalin-Fixed Paraffin Embedded Sections: 1/25-1/50 in an ABCmethod (30-60 minutes at room temperature)Staining Protocol: We suggest an incubation period of 30 minutes at room temperature. Formalin fixed paraffin embedded tissue sections require high temperature antigenunmasking with Citrate buffer, pH 6.0 prior to immunostaining. Recommended Positive Control: Tonsil. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Format Liquid
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Expiry Date 12 months
Supplier Images
Western Blotting (WB) image for anti-BCL2 antibody (B-Cell CLL/lymphoma 2) (ABIN114624) Western blot analysis of human lung cell extract with Bcl2 antibody. ABIN114624
Catalog No. ABIN114624

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)